ANTI-BRDU
- $281 - $657
- Product name: ANTI-BRDU
- CAS:
- MF: C9H11BrN2O5
- MW: 307.09804
- EINECS:
- MDL Number:MFCD00164550
- Synonyms:ANTI-BROMODEOXYURIDINE, MOUSE IGG1, MONOCLONAL PRB-1;ANTI-BROMODEOXYRUIDINE;ANTI-BROMODEOXYURIDINE;ANTI-BROMODEOXYURIDINE, 5;ANTI-BROMODEOXYURIDINE (AB-2);ANTI-BROMODEOXYURIDINE (AB-2) MOUSE MAB;ANTI-BROMODEOXYURIDINE (AB-3);ANTI-BROMODEOXYURIDINE (AB-3) MOUSE MAB
3 prices
Selected condition:
Brand
- Sigma-Aldrich
Package
- 100μG
- 0.2ML
- 100μL
- ManufacturerSigma-Aldrich
- Product numberSAB4700630
- Product descriptionMonoclonal Anti-5-bromodeoxyuridine antibody produced in mouse clone MoBu-1, purified immunoglobulin, buffered aqueous solution
- Packaging100μG
- Price$281
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberB2531
- Product descriptionMonoclonal Anti-BrdU antibody produced in mouse clone BU-33, ascites fluid, Immunohistology Grade
- Packaging100μL
- Price$499
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberB2531
- Product descriptionMonoclonal Anti-BrdU antibody produced in mouse clone BU-33, ascites fluid, Immunohistology Grade
- Packaging0.2ML
- Price$657
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich | SAB4700630 | Monoclonal Anti-5-bromodeoxyuridine antibody produced in mouse clone MoBu-1, purified immunoglobulin, buffered aqueous solution | 100μG | $281 | 2024-03-01 | Buy |
Sigma-Aldrich | B2531 | Monoclonal Anti-BrdU antibody produced in mouse clone BU-33, ascites fluid, Immunohistology Grade | 100μL | $499 | 2024-03-01 | Buy |
Sigma-Aldrich | B2531 | Monoclonal Anti-BrdU antibody produced in mouse clone BU-33, ascites fluid, Immunohistology Grade | 0.2ML | $657 | 2024-03-01 | Buy |
Properties
storage temp. :−20°C
form :buffered aqueous solution
form :buffered aqueous solution
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|